Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci
Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci
批准号:
9070878
负责人:
Haitao Hu
金额:
$13.95万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-05 至 2018-01-31
关键词:
ALVACAcquired Immunodeficiency SyndromeAddressAffectAntigensAntiviral AgentsAreaBiological AssayCD4 Positive T LymphocytesCandidaCandida albicansCell LineCellsClinicalClinical ResearchCytomegalovirusDataDevelopmentDifferentiation AntigensExposure toGene ExpressionGenesHIVHIV InfectionsHIV therapyHIV vaccineHIV-1HIV/SIV vaccineHomingHumanImmunityImmunizationInfectionKnowledgeLabelLaboratoriesLeadMeasuresMemoryMicroarray AnalysisMolecularOpportunistic InfectionsOutcomePathogenesisPathway interactionsPatientsPeripheralPeripheral Blood Mononuclear CellPhenotypePopulationPredispositionPrincipal InvestigatorProliferatingProteinsPublic HealthRNARelative (related person)ReportingResistanceRiskRoleSamplingSiteSmall Interfering RNASorting - Cell MovementSpecificitySurrogate MarkersSystemT cell responseT-LymphocyteTestingTetanus ToxoidTimeTranscriptVaccine DesignVaccinesViralbasecytokinedifferential expressiongenome-widein vitro Assayinsightmemory CD4 T lymphocytenovelpandemic diseasepathogenpermissivenesspre-clinicalprogramspublic health relevanceresearch studysensorvaccine efficacyvaccine trialvaccine-induced immunityvectorvector-inducedviral RNA
中文摘要
产品说明:更好地理解HIV感染的发病机制的一个中心问题是记忆性CD 4 T细胞如何被HIV感染并逐渐耗尽。目前对HIV感染对不同病原体或抗原特异性的CD 4 T细胞的影响知之甚少。探索这一领域对于更好地理解不同的时间安排是重要的。
艾滋病患者的机会性感染。此外,鉴定对HIV具有“抗性”的疫苗特异性CD 4 T细胞的功能群体对于HIV疫苗设计至关重要。
我们建立了一个新的系统来研究抗原特异性CD 4 T细胞对HIV的易感性,并发现不同抗原特异性CD 4 T细胞对HIV感染的易感性存在显著差异。我们的初步数据显示,与破伤风类毒素(TT)和白色念珠菌(念珠菌)特异性的CD 4 T细胞相比,这是允许艾滋病毒,巨细胞病毒(CMV)特异性的CD 4 T细胞是高度耐药的R5和X4艾滋病毒与后进入艾滋病毒的限制。我们的微阵列分析确定了一种新的病毒RNA传感器,IFIT 1,是高度上调CMV特异性CD 4 T细胞。重要的是,在我们正在进行的实验中,我们表明IFIT 1的过表达显著抑制A3 R5 CD 4 T细胞系中的HIV感染。基于已经产生的数据,我们假设IFIT 1可以抑制HIV在人原代CD 4 T细胞中的感染,并且IFIT 1的差异表达调节抗原特异性CD 4 T细胞对HIV的容许性。
我们进一步建议将新的系统和观察扩展到临床HIV疫苗研究。HIV优先感染疫苗产生的CD 4 T细胞会降低疫苗诱导的免疫效率。我们的假设是,保护性HIV疫苗将诱导一种疫苗特异性CD 4 T细胞,这些细胞对HIV“不容易易感”,并且不同的候选HIV疫苗(例如不同的载体)诱导疫苗特异性CD 4 T细胞的不同表型,这可能显著影响其对HIV的敏感性。我们会检测外周血
来自三个已完成的HIV疫苗试验的单核细胞样本:RV 144(ALVAC)、RV 158(MVA)和IPVC 001(Ad 26)。我们的假设将在2个特定目的中得到解决:1)确定IFIT 1在调节人类抗原特异性CD 4 T细胞对HIV的易感性中的作用,并进一步探索IFIT 1抑制HIV的机制; 2)研究不同HIV疫苗诱导的抗原特异性CD 4 T细胞对HIV感染的易感性以及HIV疫苗试验中的相关表型。
这些研究是探索性的,但有望为以下方面提供新的见解:1)了解艾滋病患者CMV特异性T细胞免疫持续存在的机制; 2)确定一种新的抗HIV分子,其抑制机制/途径以前未被确定,可能导致开发新的HIV治疗方法; 3)更好地理解疫苗产生的CD 4 T细胞免疫的质量,并提供关于是否以及如何通过HIV疫苗诱导功能性的“HIV抗性”CD 4 T细胞的概念知识的证明。
英文摘要
DESCRIPTION: A central question to better understanding the pathogenesis of HIV infection is how memory CD4 T cells are infected and progressively depleted by HIV. Little is currently known about the impact of HIV infection on CD4 T cells of different pathogen or antigen specificities. Exploring this area is important for better understanding of the timing of different
opportunistic infections in AIDS patients. In addition, identification of a functional population o vaccine-specific CD4 T cells that is "resistant" to HIV is critical for HIV vaccine design.
We have established a novel system for studying the susceptibility of antigen-specific CD4 T cells to HIV, and have found that different antigen-specific CD4 T cells manifest marked differences in susceptibility to HIV infection. Our preliminary data show that compared to CD4 T cells specific to tetanus toxoid (TT) and Candida albicans (Candida), which are permissive to HIV, cytomegalovirus (CMV)-specific CD4 T cells are highly resistant to both R5 and X4 HIV with post-entry HIV restriction. Our microarray analysis identified a novel viral RNA sensor, IFIT1 that is highly upregulated in CMV-specific CD4 T cells. Of importance, in our ongoing experiments, we show that over-expression of IFIT1 significantly inhibits HIV infection in A3R5 CD4 T cell line. Based on data already generated, we hypothesize that IFIT1 can inhibit HIV infection in human primary CD4 T cells and differential expression of IFIT1 regulates the permissiveness of antigen-specific CD4 T cells to HIV.
We further propose to extend the novel system and observations to clinical HIV vaccine studies. Preferential infection of vaccine-generated CD4 T cells by HIV reduces the efficiency of vaccine-induced immunity. Our hypothesis is that a protective HIV vaccine would induce a type of vaccine-specific CD4 T cells that are "not readily susceptible" to HIV, and that different candidate HIV vaccines (e.g. different vectors) induce distinct phenotypes of vaccine-specific CD4 T cells that may significantly impact their sensitivities to HIV. We will test peripheral blood
mononuclear cell samples from three completed HIV vaccine trials: RV144 (ALVAC), RV158 (MVA) and IPVC001 (Ad26). Our hypotheses will be addressed in 2 Specific Aims: 1) To determine the role of IFIT1 in regulating the susceptibility of human antigen-specific CD4 T cells to HIV and to further explore the mechanisms for inhibition of HIV by IFIT1; 2) To investigate the susceptibilities of different HIV vaccine-induced, antigen-specific CD4 T cells to HIV infection and the associated phenotypes in HIV vaccine trials.
The proposed studies are exploratory, but expected to provide new insights to: 1) understand the mechanisms for the persistence of CMV-specific T cell immunity in AIDS patients; 2) identify a novel anti-HIV molecule with previously unidentified inhibitory mechanisms/pathways that could lead to the development of novel HIV therapies; 3) better understand the quality of vaccine-generated CD4 T cell immunity and to provide proof of concept knowledge on whether and how to induce functional, "HIV-resistant" CD4 T cells by an HIV vaccine.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.1700698
发表时间:
2017-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Liu F, Niu Q, Fan X, Liu C, Zhang J, Wei Z, Hou W, Kanneganti TD, Robb ML, Kim JH, Michael NL, Sun J, Soong L, Hu H]
通讯作者:
Hu H
DOI:
10.1586/14760584.2016.1147354
发表时间:
2016-06
期刊:
Expert review of vaccines
影响因子:
6.2
作者:
[Hu H, Liu F, Kim J, Ratto-Kim S]
通讯作者:
Ratto-Kim S
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
非小细胞肺癌脑转移患者的突变状态和切除后生存:生物标志物驱动治疗的影响。
DOI:
10.3171/2020.10.jns201787
发表时间:
2022
期刊:
Journal of neurosurgery
影响因子:
4.1
作者:
[Shah,PavanP, Franke,JenniferL, Medikonda,Ravi, Jackson,ChristopherM, Srivastava,Siddhartha, Choi,John, Forde,PatrickM, Brahmer,JulieR, Ettinger,DavidS, Feliciano,JosephineL, Levy,BenjaminP, Marrone,KristenA, Naidoo,Jarushka, Redmond,]
通讯作者:
Redmond,
Modulation of BRD4 to epigenetically suppress HIV
-
批准号:10624845
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2021
-
负责人:Haitao Hu
-
依托单位:
Modulation of BRD4 to epigenetically suppress HIV
-
批准号:10326722
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2021
-
负责人:Haitao Hu
-
依托单位:
Modulation of BRD4 to epigenetically suppress HIV
-
批准号:10434159
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2021
-
负责人:Haitao Hu
-
依托单位:
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV
-
批准号:10115603
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2020
-
负责人:Haitao Hu
-
依托单位:
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV
-
批准号:10010193
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2020
-
负责人:Haitao Hu
-
依托单位:
Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci
-
批准号:8732199
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2014
-
负责人:Haitao Hu
-
依托单位:
海外基金